The inherited connective tissue disorders are a clinically and genetically heterogeneous assembly of disorders presenting with mechanical failure of collagen rich tissues such as bone, skin, ligaments, tendons, and blood vessel walls. The most frequently encountered clinical groups are osteogenesis imperfecta, in which bones have an increased susceptibility to fracture, Marfan's syndrome, and Ehlers-Danlos syndrome, but within these categories there is also a great deal of variation. Since the extracellular protein collagen is the major mechanical component of the affected tissues, it has reasonably been supposed that abnormalities in collagen may be responsible. Owing in part to the nature of the protein, specific biochemical evidence to support such a hypothesis has been difficult to establish. Nevertheless, in vivo and in vitro differences in collagen stability, chain length, or metabolism have been reported in individual cases or unrelated groups. In a few rare recessive forms of the Ehlers-Danlos syndrome the effects on collagen are due to deficiencies in enzymes which modify procollagen chains after translation. This explanation does not cover the majority of cases and it is likely that some causal mutations lie within or close to structural genes coding for collagen. By taking advantage of DNA sequence polymorphisms revealed by restriction endonuclease digestion, it is usually possible to test this hypothesis for a given collagen gene.
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Here we report results using the human pro al(II) nhardts, 20 ig ml-' denatured salmon sperm DNA, and, when using the whole cosmid, 20 ig mldenatured human placenta DNA to compete with repetitive sequences in the probe. Filters were washed twice in 2 x SSC at room temperature, then twice in 0-1 x SSC, 0-1% SDS at 65°C, air dried, and exposed to Fuji RX film.
Results
Two restriction site polymorphisms were used in this 187 analysis. The variation revealed by HindIll digestion has been described in detail elsewhere.5 Another polymorphism was detected by PvuII digestion when a 3-3 kb fragment was cleaved into two fragments of 1-7 and 1-6 kb when the site was present (+ phenotype). When the whole cosmid was used as a probe, the 1-6 kb fragment was masked by a coincident non-variable fragment (fig la) (2) 11.5 carries the Oa-gene and has a COL2A1 genotype AB. Both I11.9 and 111.11 receive a paternal A haplotype but only 111.11 inherits the OIa-gene. These examples of discordant segregation assume complete penetrance of the Oa-gene. Careful clinical assessment of the three normal subjects did not reveal any features of the disease and so it is unlikely that any had inherited the Ola-gene. PEDIGREE b (FIG 3) (1) Both 11.6 (BD) and 111.3 (AA) carry the mutant gene for this pedigree (OIb-) yet they do not share a common COL2A1 haplotype.
(2) The three affected subjects in generation II, 11. 1 (AD), 11.5 (AB), and 11.6 (BD), do not share a common haplotype. (3) 
